Not yet recruiting
Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
NCT07243938
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
- Locations
-
Not specified